Ryman Healthcare Limited
RYHTY
$7.45
-$0.04-0.53%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 10.42% | 11.89% | 13.47% | 11.63% | 7.19% |
| Total Other Revenue | 61.79% | 83.32% | 118.10% | 184.14% | 367.54% |
| Total Revenue | 13.09% | 15.10% | 17.31% | 15.87% | 11.66% |
| Cost of Revenue | 22.30% | 19.75% | 16.99% | 12.16% | 4.73% |
| Gross Profit | -58.84% | -30.90% | 21.79% | 73.12% | 131.27% |
| SG&A Expenses | -- | -- | -- | -- | -- |
| Depreciation & Amortization | 17.01% | 9.25% | 1.59% | -7.15% | -16.49% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 21.98% | 19.09% | 15.99% | 10.81% | 3.15% |
| Operating Income | -135.09% | -109.02% | 579.68% | 512.80% | 396.97% |
| Income Before Tax | -200.46% | -186.80% | -176.45% | -105.24% | -84.52% |
| Income Tax Expenses | 81.39% | -1.54% | -228.71% | -2,287.48% | -315.14% |
| Earnings from Continuing Operations | -134.62% | -116.27% | -97.67% | -71.69% | -62.00% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -134.62% | -116.27% | -97.67% | -71.69% | -62.00% |
| EBIT | -135.09% | -109.02% | 579.68% | 512.80% | 396.97% |
| EBITDA | -56.72% | -17.27% | 78.93% | 124.36% | 157.95% |
| EPS Basic | -132.21% | -113.39% | -98.28% | -77.82% | -70.32% |
| Normalized Basic EPS | 46.57% | 62.20% | 75.48% | 8.84% | -256.91% |
| EPS Diluted | -132.50% | -113.50% | -98.28% | -77.82% | -70.32% |
| Normalized Diluted EPS | 46.57% | 62.20% | 75.48% | 8.84% | -256.91% |
| Average Basic Shares Outstanding | 12.70% | 22.09% | 33.18% | 27.69% | 22.03% |
| Average Diluted Shares Outstanding | 12.70% | 22.09% | 33.18% | 27.69% | 22.03% |
| Dividend Per Share | -- | -- | -- | -100.00% | -100.00% |
| Payout Ratio | -- | -- | -- | -1.00% | -1.00% |
